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Abstract Age-relatedmacular degeneration (AMD) is an
eye disease underlined by the degradation of retinal pig-
ment epithelium (RPE) cells, photoreceptors, and
choriocapillares, but the exact mechanism of cell death in
AMD is not completely clear. This mechanism is impor-
tant for prevention of and therapeutic intervention in
AMD, which is a hardly curable disease. Present reports
suggest that both apoptosis and pyroptosis (cell death
dependent on caspase-1) as well as necroptosis
(regulated necrosis dependent on the proteins RIPK3 and
MLKL, caspase-independent) can be involved in the
AMD-related death of RPE cells. Autophagy, a cellular
clearing system, plays an important role in AMD patho-
genesis, and this role is closely associated with the activa-
tion of the NLRP3 inflammasome, a central event for
advanced AMD. Autophagy can play a role in apoptosis,
pyroptosis, and necroptosis, but its contribution to AMD-
specific cell death is not completely clear. Autophagy can
be involved in the regulation of proteins important for
cellular antioxidative defense, including Nrf2, which can
interact with p62/SQSTM, a protein essential for
autophagy. As oxidative stress is implicated in AMD
pathogenesis, autophagy can contribute to this disease by
deregulation of cellular defense against the stress.
However, these and other interactions do not explain the
mechanisms of RPE cell death in AMD. In this review, we
present basic mechanisms of autophagy and its involve-
ment in AMD pathogenesis and try to show a regulatory
role of autophagy in RPE cell death. This can result in
considering the genes and proteins of autophagy as mo-
lecular targets in AMD prevention and therapy.
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Autophagy is an important process resulting in lysosom-
al degradation of unused and damaged cellular compo-
nents, which can produce energy and nutrition necessary
for the cell homeostasis and functions (reviewed in
Mizushima and Komatsu (2011)). Autophagy plays a
role in the pathogenesis of many human diseases, in-
cluding cancer, diabetes, neurodegenerative disorders,
and infectious diseases (reviewed in Jing and Lim
(2012)). These include age-related macular degenera-
tion (AMD), an eye disease, which is a major reason of
blindness in the elderly in developed countries
(Ferrington et al. 2016; Reibaldi et al. 2016). It is a
complex disease occurring in its advanced stage in two
major forms: dry and wet. Unfortunately, there is no
effective treatment targeting both AMD forms. As
AMD is a degenerative disease, its expression is asso-
ciated with the degeneration of important functional
parts of the retina, resulting from the death of retinal
pigment epithelium (RPE) cells, photoreceptors, and
choriocapillaris (Fig. 1).
Various cell death modes are considered to play a role
in AMD, including apoptosis, pyroptosis (cell death
dependent on caspase-1), and necroptosis (regulated
necrosis dependent on the proteins RIPK3 and MLKL,
independent of caspases). However, there are some
conflicting reports on the regulation of the choice of a
particular cell death type in AMD, but surely, cells do
not simply Bchoose^ a certain death pathway, as all
different pathways influence each other in a molecular
crosstalk. Aberrant autophagy has been mentioned fre-
quently to associate with AMD, and autophagy itself is
considered a kind of programmed cell death, so it can
play a role in cell death in AMD (Shimizu et al. 2010)
(reviewed in Tsujimoto and Shimizu (2005)). In addi-
tion, apoptotic signaling can directly regulate autophagy
and vice versa (reviewed in Yonekawa and Thorburn
(2013)). In general, aberrant regulation of programmed
cell death by autophagy is linked with many human
diseases (reviewed in Mizumura et al. (2014a))
(Mizumura et al. 2014b). Therefore, it seems reasonable
and justified to study the role of autophagy in the regu-
lation of RPE cell death in AMD.
Age-related macular degeneration—an eye disease
involving extensive cell death
Age-related macular degeneration is an eye disease af-
fecting mainly elderly people, and it is a major cause of
blindness among individuals over 65 years in developed
countries (Reibaldi et al. 2016). As mentioned, two
basic forms of advanced AMD are dry (non-exudative)
and wet (exudative), but early dry AMD is hardly de-
tectable, and its advanced form, called geographic atro-
phy (GA), which is associated with a massive loss of
retinal cells, is responsible for a substantial part of
blindness related to AMD (Klein et al. 2007).
AMD is a complex disease with genetic and environ-
mental factors involved in its etiology. Although the
exact mechanism of its pathogenesis is not known,
oxidative stress and inflammation can play a role
(reviewed in Kauppinen et al. (2016)). However, it is
not exactly known how oxidative stress can contribute
to the degeneration of RPE cells, and two mechanisms
of their death, apoptosis and necrosis, are considered
and supported by both in vivo and in vitro studies.
Apoptosis is frequently attributed to RPE cell death in
AMD, and both the caspase-dependent and -
independent pathways are suggested to be involved
(reviewed in Adler et al. (1999), Ferrington et al.
(2016), and Hanus et al. (2015a)) (Dunaief et al. 2002;
Hanus et al. 2015b; Rodrigues et al. 2011; Tsao et al.
2006; Wang et al. 2012). Hanus et al. (2013) suggested
that necrosis, and not apoptosis, is a dominant cell death
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in RPE cells subjected to oxidative stress. In that study,
the contribution of autophagy to RPE cell death was not
observed. We also noted a dominancy of necrotic cell
death in ARPE-19 cells treated with tert-butyl
hydroxyperoxide (Tokarz et al. 2016). However, the
problem of the involvement of necrosis in RPE cell
death is still controversial and needs further studies.
Several issues should be taken into account in con-
sidering mechanisms of cellular death in AMD, among
them two seem to be especially important. Firstly, AMD
is a disease, which phenotype can dramatically change
with its progression. Secondly, the region of the retina
affected in AMD contains a highly heterogeneous pop-
ulation of cells, including RPE cells, choriocapillares,
and neurons. The survival of neurons in the retina is
regulated in a muchmore complex way than that of RPE
cells, as these post-mitotic cells must function within
neuronal circuits in the organism (reviewed in Kole et al.
(2013)). Many factors can contribute to survival and
death of retinal cells, but some of them can act differ-
ently in different cells, depending on their receptors
(reviewed in Adler et al. (1999)). This mechanism is
evenmore complicated by the concept that AMD can be
associated with disturbed cell communication (reviewed
in Nakahara et al. (2013)). This effect can result in a
receiving of a death signal by one type of cells and
transmitting it, in a changed form, to other types.
Alternatively, cells receiving this primary signal can
change the local environment, which affects other cells
leading to their degeneration. Recruitment of inflamma-
tory cells, changed cellular phenotypes, and autocrine
and paracrine signaling alterations certainly modify the
local tissue environment that may finally lead to cell
death.
Autophagy—at the crossroad between cell death
and survival
Cytosolic components, including organelles, undergo
changes, which can result in their uselessness and
should be eliminated from, or better, being recycled in
the animal cell. This is important also for providing
building block to assemble needed biomolecules and
fuel for energy-cost metabolic processes. Autophagy,
sometimes called self-eating, directs degradation of un-
necessary cellular molecules and organelles by deliver-
ing them to lysosomes, in which they are broken down
by hydrolytic enzymes. Autophagy is also important as
a defense system against pathogens as it can be involved
in the degradation of proteins of invasive microbes.
Three basic types of autophagy are distinguished:
macroautophagy, chaperone-mediated autophagy
(CMA), and microautophagy (reviewed in Mizushima
Fig. 1 Age-related macular
degeneration (AMD) affects the
macula, a specific part of the
central retina. It involves
extensive death of retinal pigment
epithelium cells, photoreceptors,
and choriocapillaris and leads to a
progressive loss of central vision
and eventually blindness
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and Komatsu (2011)). Macroautophagy is mediated
by the formation of autophagosome, a double-
membrane vacuole, containing materials to be de-
graded (cargo). Autophagosome combines with ly-
sosome, resulting in a structure called autolysosome,
in which the final degradation of the cargo occurs.
Microautophagy is conceptually the simplest mech-
anism of autophagy as it involves engulfing of the
cargo by the lysosome, initiated by the invagination
of its membrane. Substrates for CMA are proteins
with the KFERQ amino acid motif, which are un-
folded by the HSC70 protein, a chaperone, assisted
by several other proteins. Macroautophagy, which is
considered as the major autophagic pathway and has
been the most extensively studied among all types of
autophagy, will be further referred to as autophagy.
It involves a combined action of autophagosome and
lysosome, in which the degrading action of lysosom-
al enzymes is supported by several autophagy-
related proteins (Atgs) (reviewed in Blasiak et al.
(2012)). The critical event in the mTOR (mammali-
an target of rapamycin)-dependent formation of
autophagosome is the inactivation of mTOR,
resulting in an immediate dephosphorylation of
Atg13, activation of serine/threonine kinases
(ULKs), and recruitment of the FIP-200 protein
(Fig. 2a). Autophagy can be also initiated in various
mTOR-independent mechanisms (reviewed in
Sarkar (2013)). Detailed mechanisms of signaling
in autophagy have been described in many excellent
reviews (Boya et al. 2013; Gallagher et al. 2016;
Yang and Klionsky 2010). Autophagosomes are
formed in the vicinity of endoplasmic reticulum
(ER), but it is not known, whether ER membrane
directly participates in the development of
autophagosome (reviewed in Mizushima et al.
(2011)).
The involvement of autophagy in removing
faulty cellular components makes it as an internal
quality control mechanism in the cell. This has led
to the concepts of general autophagy called non-
selective autophagy and selective autophagy—the
latter is directed to selective degradation of specif-
ic cellular components, first of all proteins or
invading pathogens (reviewed in Mizushima and
Komatsu (2011)). It is anticipated that even 1.5%
of all cellular proteins in rat liver can be degraded
by autophagy per hour in normal nutrition (Ezaki
et al. 2011) (reviewed in Ueno et al. (2012)).
Selective autophagy plays an important role in
tissue differentiation, contributing to different
transfer of genetic information in different cells.
One of the most significant substrates for selective
autophagy is the p62 protein (p62/SQSTM1),
interacting with microtubule-associated protein
light chain 3 (LC3), facilitating degradation of
ubiquitinated substrates with its own subsequent
degradation in autophagosome (reviewed in
Johansen and Lamark (2011)). Therefore, p62 can
be considered a marker of autophagic flux
(Johansson et al. 2015; Viiri et al. 2013). The
accumulation of p62 is associated with disturbed
autophagy and observed in serious diseases includ-
ing brain and liver cancers, Parkinson disease,
Alzheimer disease, and steatohepatitis (Zatloukal
et al. 2002). p62 decides the fate of the cell since
it can be involved in pro-survival pathway by
activation of the TRAF6 (TNF receptor-associated
factor 6)-NF-κB pathway (Linares et al. 2013). On
the other hand, p62 can activate caspase-8 through
its polyubiquitination and association with death-
inducing signaling complex (DISC), leading to cell
death (Hughes et al. 2009; Singh et al. 2014).
Various interactions of p62 include the stabiliza-
tion of Nrf2 and activation of the transcription of
Nrf2-related genes, including those which are cru-
cial for cellular antioxidant defense (reviewed in
Bryan et al. (2013)) (Johansson et al. 2015; Wang
et al. 2014). Nrf2 was shown to transcriptionally
regulate autophagy genes in a mouse model of
Alzheimer disease (Pajares et al. 2016). As men-
tioned, to protect against oxidative stress, Nrf2 can
cooperate with Keap1, but the activation of Nrf2
can promote autophagic degradation of Keap1
(Park et al. 2015). It seems that the role Nrf2
plays in autophagy, especially through the interac-
tion with p62, strongly depends on the cellular
context as there are many reports suggesting dif-
ferent actions of this protein in different cellular
states (reviewed in Taniguchi et al. (2016)).
Autophagy plays a number of pro-survival functions
in the cell (Fig. 2b). The production of amino acids is
dependent on the availability of their components,
which are normally supplied with nutrition, but in star-
vation, they can be delivered by increased autophagy,
which results in increased amino acid production from
degraded polypeptides (Vabulas and Hartl 2005).
Amino acids can be included in the tricarboxylic acid
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(TCA) cycle to produce ATP, and autophagy was shown
to play a role in this process by regulating the flow of
metabolites in the TCA cycle (Guo et al. 2011).
The recycling properties of autophagy—degrading
of unneeded material to produce components for
new blocks—make it a suitable tool for cell reno-
vation during differentiation and development
(reviewed in Mizushima and Komatsu (2011)).
This is especially important just after fertilization,
when the maternal material should be replaced by
that encoded by the zygotic genome (Tsukamoto
et al. 2008a, b). In that stage of development,
autophagy plays an important role in establishing
a maternal line of inheritance of mitochondrial
DNA (mtDNA), since it is crucial for selective
degradation of paternal mitochondria (reviewed in
Sato and Sato (2013a, b)) (Zhou et al. 2011a, b).
In general, degradation of mitochondria in the
autophagic process is called mitophagy, and elim-
ination of paternal mitochondria in early embryos
by allogeneic organelle autophagy is called
allophagy (reviewed in Sato and Sato (2013b)).
Results of several studies suggest that autophagy
plays a role in the pathogenesis of various eye diseases,
Fig. 2 Damaged and unneeded proteins and organelles as well as
other cellular component-derived objects (cargo) are enclosed by
an isolation membrane to form an autophagosome, which com-
bines with the lysosome forming an autolysosome, where the
cargo is degraded by a concerted action of lysosomal enzymes
and autophagy-related proteins (Atgs) giving various products,
including amino acids, which can be used by the cell (small
circles). Many proteins are involved in this process, but in mam-
malian target of rapamycin ( mTOR)-dependent autophagy, the
key event in the formation of the autophagosome is inactivation of
mTOR, resulting in recruitment of the FIP200 and many Atg
proteins. Microtubule-associated protein 1A/1B-light chain 3
(LC3) is conjugated with phosphatidylethanolamine (PE) to bind
autophagosomemembrane, but then, it is degraded (a). Autophagy
plays many important functions in the cell, which can be divided
into two classes, pro-life and pro-death, which are associated with
coping with unfavorable extra- and intracellular environment and
functions contributing to elimination of faulty cells (b)
Cell Biol Toxicol (2017) 33:113–128 117
including those involving retinal degeneration
(reviewed in Li et al. (2015)).
Autophagy—an important player
in the pathogenesis of age-related macular
degeneration
As autophagy plays an important role in the homeostasis
of RPE cells, its impairment can lead to accumulation of
damaged organelles and various non-functional or toxic
proteins, including lipofuscin, and promote the forma-
tion of drusen, typical for AMD. Drusen contains lipids,
carbohydrates, proteins, and cellular debris, which are
processed by autophagy. Therefore, impaired autophagy
can contribute to drusen formation and in this way can
be associated with AMD (Fig. 3a). However, no causa-
tive relationship follows from this association since
there is no solid evidence that drusen can cause AMD
(reviewed in Khan et al. (2016)). In general, a decrease
of autophagic activity with age is observed, which can
contribute to age-related diseases, including AMD
(reviewed in Cuervo (2008) and Kaarniranta et al.
(2013)) (Linares et al. 2013). However, it is not exactly
known which autophagic pathway contributes mostly to
this effect. Moreover, the role of different autophagic
mechanisms in the retinal physiology and pathology is
not completely clear (Rodriguez-Muela et al. 2013).
However, the relationship between the presence of
drusen in AMD and autophagy impairment can be seen
in a wider context, as age-related dysfunction of autoph-
agy can lead to the formation and accumulation of
drusen, containing cellular debris, lipids, carbohydrates,
and proteins that are believed to be delivered from the
RPE cells. Therefore, the association between different
autophagic pathways and drusen formation could be
informative for the contribution of these processes to
AMD biogenesis and progression.
Not only autophagy but also proteosomal-mediated
proteolysis can play a role in AMD.We showed that the
expression of p62/SQSTM1 was post-transcriptionally
regulated by the ELAVL1/HuR factor, when
proteosomal activity was inhibited in ARPE-19 cells
(Viiri et al. 2013). Therefore, p62/SQSTM1 can be
considered a central protein for the involvement of
disturbed autophagy and proteolysis in drusen formation
and the role of this effect in AMD pathogenesis.
Samples from AMD patients showed a stronger accu-
mulation of p62/SQSTM1 rather than ELAVL1/HuR,
suggesting a greater contribution of autophagy in clear-
ing protein aggregates than proteasome-mediated prote-
olysis, and in this way, autophagy can be seen as the
main mechanism involved in the protein aggregation in
RPE cells (Fig. 3b). Since increased protein aggregation
can contribute to inflammasome activation and tissue
Fig. 3 Extracellular drusen deposition can be detected in early dry
age-related macular degeneration (AMD) (black arrow) if there is
not sufficient protein clearance dependent on autophagy. Ad-
vanced dry AMD can lead to geographic atrophy with extensive
cell death (blue arrow) (a). Protein waste material can be cleared
by both autophagy and proteasomal degradation. These two path-
ways can cooperate and the interaction between p62/SQSTM1 and
ELAVL1/HuR factors is critical for this cooperation. However,
p62/SQSTM1 is preferentially accumulated over ELAVL1/Hur in
AMD-inducing activation of the NLRP3 inflammasome, suggest-
ing a greater contribution of impaired autophagy than proteasomal
degradation in this disease (b)
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injury, it may be speculated that decreased autophagy
and increased inflammation participate in drusen bio-
genesis (Liu et al. 2016; Wang et al. 2014) (reviewed in
Wang et al. (2016a, b)).
Mitter and coworkers observed over 100% in-
crease in the number of autophagosomes in RPE
of two mouse models of AMD and human AMD
donors (Mitter et al. 2014). A significant increase
in the expression of the LC3, Atg7, and Atg9
proteins was observed in SOD2-knocked mice in
their early stage of development. Similar increase
was noted in the tissue sections from AMD do-
nors. However, both experimental animals and
AMD donors showed a decreased autophagosome
fractional volume in both early and late stages of
AMD as compared to controls. The results obtain-
ed in that work are important for several reasons.
Firstly, increasing autophagy with age in mice
RPE is somehow surprising in the context of gen-
eral decrease of autophagy with age. However, at
this point, two features should be distinguished:
autophagy potential and autophagy activity. One
can assume that overall autophagy capacity de-
creases with age, but this does not exclude that
there is an increased autophagy flux in the initial
phase of oxidative stress, when a large amount of
damaged proteins and other molecules is produced.
On the other hand, this can lead to overloading of
the autophagosomal system, resulting in a decrease
in autophagy activity. These effects can be associ-
ated with initial phase of AMD. The authors
showed a dynamic character of autophagy in
RPE cells in oxidative stress, which was displayed
in increased and decreased autophagy evoked by
acute and chronic stress, respectively. The initial
increase in autophagy was attributed to increased
number of autophagosomes, which can result from
a reduced effectiveness of lysosomes to degrade
autophagosomal content. However, the authors
did not directly check this possibility, as it is
technically challenging, but this feature can be
associated with AMD (reviewed in Kaarniranta
et al. (2013) and Mitter et al. (2012)).
Five autoreactivity targets were found in the age-
related maculopathy ancillary (ARMA) study to
identify and characterize human macula autoantigens
in sera of AMD subjects: two belonging to heat
shock protein 70 (HSP70) family HSPA8/9, another
heat shock protein HSPB4, also known as alpha-
crystallin A chain (CRYAA), Annexin A5, and
Protein S100-A9 (Iannaccone et al. 2015). Although
these proteins can be involved in various effects and
mechanisms important for AMD development, in-
cluding immunomodulation and antioxidative and
anti-apoptotic protection, they all can participate in
autophagy activation, confirming an important role of
this process in AMD pathogenesis.
The critical role of autophagy in the homeostasis of
aging RPE was shown in mice with knockout in the
gene coding for the RB1CC1/FIP200 protein, which is
essential for autophagy induction (Yao et al. 2015).
These mice developed age-related degeneration of
RPE, which was featured by atrophic patches, subretinal
migration of microglia, deposition of oxidatively dam-
aged proteins, and choroidal neovascularization.
Degenerated RPE was linked with the loss of neighbor-
ing photoreceptors. Although it is known that A2E, a
component of lipofuscin exerting a toxic effect on RPE
cells, is deposited in these cells with age, its exact
mechanism contributing to AMD pathogenesis is not
completely known. It was shown that A2E induced
autophagy and decreased the viability of RPE cells,
indicating another mechanism of the involvement of
autophagy to AMD pathogenesis (Guha et al. 2013;
Zhang et al. 2015). In general, the interrelationships be-
tween autophagy-lysosomal and the ubiquitin-proteosome
pathways can be important for the pathogenesis of AMD,
in which accumulation of non-functional proteins is
observed (Zhan et al. 2016). It was observed that impaired
autophagy resulted in a decreased proteosomal-mediated
proteolysis, suggesting that autophagy can be a principal
system for clearance of misfolded and otherwise damaged
proteins in human RPE cells.
Oxidative stress plays a role inmany aspects of AMD
pathogenesis, and cellular antioxidant response, which
can be seen as an AMD protective mechanism, is linked
to autophagy through the p62/Keap1/Nrf2 pathway
(Johansson et al. 2015; Wang et al. 2014). However,
interconnections between autophagy, oxidative stress,
and AMD can be wider as autophagy can be associated
with other elements of antioxidant defense, including
DNA repair (reviewed in Czarny et al. (2015) and
Filomeni et al. (2015)). As DNA damage response
(DDR) can be important for AMD, its association with
autophagy can play a role in AMD pathogenesis. As we
showed, variability of DNA repair genes, including the
base excision repair pathway hOGG1 and MUTYH
genes, was associated with AMD (reviewed in Blasiak
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et al. (2012)) (Synowiec et al. 2012). However, the exact
role of autophagy in DDR or rather an association
between these two phenomena was not determined.
Likely, the most direct link between them is expressed
by mitophagy, when mitochondria with highly damaged
DNA are degraded (Kurihara et al. 2012). This is a
specific feature of DDR in mitochondria, as in the
nucleus, seriously damaged DNA can induce apoptosis
or, in certain circumstances, be tolerated resulting in
mutations (reviewed in Sharma et al. (2013)).
Although it is known that reactive oxygen species
(ROS) can induce autophagy in starvation conditions,
it is not known which exactly species are responsible for
this effect (reviewed in Filomeni et al. (2010)). Both
superoxide radical (O2
•–) and hydrogen peroxide (H2O2)
were considered species involved in autophagy trigger-
ing in starvation conditions (Chen et al. 2009; Scherz-
Shouval et al. 2007a; Scherz-Shouval et al. 2007b;
Zhang et al. 2013). In general, ROS can be considered
inducers of autophagy (reviewed in Azad et al. (2009;
Levonen et al. 2014). Moreover, some data suggest that
mitochondria are the main source of ROS needed for the
induction of autophagy (Scherz-Shouval et al. 2007a;
Scherz-Shouval et al. 2007b) (reviewed in Scherz-
Shouval and Elazar (2007)). Therefore, it seems that
there is a logical chain of events: starvation increases
energetic demands, which in turn increase ATP produc-
tion in mitochondria and elevate ROS level. However,
the action of ROS, especially in oxidative stress, can
induce also other mechanisms, which can interfere with
autophagy.
A diet rich in polyunsaturated fatty acid (PUFA) is
considered an AMD risk factor, but the question wheth-
er it is an independent factor is not completely answered
(reviewed in Lambert et al. (2016)). However, one of the
mechanisms underlying this association can result from
the peroxidation of PUFA as it results in the formation of
lipid peroxidation products, which can be detrimental
for the cell (reviewed in Ayala et al. (2014)). This effect
can be associated with wet AMD as it was observed that
malondialdehyde (MDA), a major lipid peroxidation
product, induced VEGF secretion, which was associated
with choroidal neovascularization, typical for wet AMD
(Ye et al. 2016). Moreover, MDA also induced autoph-
agy impairment in AMD patients and ARPE-19 cells,
observed as changes in the expression of Beclin 1,
LC3B, and p62 proteins. Therefore,MDA accumulation
can be an important step in AMD pathogenesis related
to oxidative stress and autophagy.
Autophagy, apoptosis, pyroptosis, and necroptosis
in AMD
Autophagy improves cell survival through the recycling
of metabolic precursors and removing damaged proteins
and organelles from the cell. Additionally, autophagy
modulates inflammation responses and cell death path-
ways and thereby influences disease pathogenesis, in-
cluding AMD (reviewed in Kaarniranta et al. (2013) and
Nikoletopoulou et al. (2013)). Autophagy inhibition
resulted in inflammasome activation and increased an-
giogenesis in RPE cells exposed to rotenone, an inhib-
itor of the electron transport chain in mitochondria (Liu
et al. 2016). Inhibited autophagy induced caspase-3-
mediated cell death, suggesting that apoptosis can be
over positive control of autophagy in RPE cells.
Hydrogen peroxide at high concentrations induced
necrotic cell death, mediated by the activation of
poly(ADP-ribose) polymerase 1 (PARP1) in human
RPE cells in culture, and nicotinamide adenine dinucleo-
tide (NAD+) protected the cells against this effect (Zhu
et al. 2016). Using autophagy inhibitors, it was shown
that autophagy was responsible for that protective effect.
Therefore, two important compounds can play a role in
the regulation of cellular death in AMD: NAD+ and
PARP1, and their action can be related to autophagy.
Ultrastructural pathology studies suggest that the pre-
dominant mechanisms of cellular death in AMD were
pyroptosis and necroptosis, while apoptosis could have a
minor contribution (reviewed in Ardeljan et al. (2014)).
Mitochondria seem to be an important element of
regulation of cellular death in AMD for several reasons.
Firstly, they are important for the intrinsic apoptosis
pathway (Criollo et al. 2007) (reviewed in Kroemer
et al. (2007)). Secondly, they are linked to inflammatory
response and pyroptosis (Zhou et al. 2011a, b). Thirdly,
the process of cell degeneration, crucial for acquiring
AMD phenotype, can be associated with dysfunctional
mitochondria (reviewed in Carelli et al. (2002)).
Autophagy proteins can inhibit inflammasome activa-
tion by reducing the release of mitochondrial DNA
(Nakahira et al. 2011).
As AMD is associated with inflammation, pyroptosis
could be initiated at its specific level. This was confirmed
by the presence of caspase-1 in theNLRP3 inflammasome
(Wang et al. 2016a, b). Results of some studies suggest
that pyroptosis can be functionally linked with autophagy.
It was shown that inhibition of autophagy stimulated
pneumococcus-induced pyroptosis and protected
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microglia cells against pyroptosis (Kim et al. 2015).
Extensive studies led by Hanus et al. (2015b) suggest that
necroptosis can dominate in RPE cell death associated
with dry AMD.
An interplay between apoptosis and pyroptosis was
observed in research, in which ARPE-19 cells and pri-
mary human RPE cells were loaded with lipofuscin and
irradiated with blue light (Brandstetter et al. 2016)
(Fig. 4). The irradiated lipofuscin-mediated oxidative
stress resulted in damage to the lysosomal membrane
and leakage of lysosomal enzymes into the cytosol and
eventually cell death by apoptosis. However, this mode of
cellular death was changed into pyroptosis after the
NLRP3 inflammasome priming by IL-1α or C5a, a com-
plement activation product, or conditioned media for
pyroptotic cells. Activation of the NLRP3 inflammasome
is an important mechanism regulating cell death in RPE,
and it was shown to occur in AMD-affected RPE cells
(Gelfand et al. 2015; Tseng et al. 2013). Therefore, results
of these studies suggest that inflammasome activation
alters the preferable cell death mode induced by photo-
oxidation from apoptosis to pyroptosis.
The Alu transposons are common in the human ge-
nome, and the amount of their transcripts is regulated by
the DICER1 RNase, which activity was reported to de-
crease and result in accumulation of the transcripts in the
eye of patients with AMD (Kaneko et al. 2011) (Fig. 5).
These RNAs are toxic for RPE and can induce the death of
RPE cells (Tarallo et al. 2012). Tarallo et al. (2012) devel-
oped a concept that Alu RNAs were recognized by an
innate immune system. They showed that Alu RNA accu-
mulation, likewise DICER1 deficiency, activated the
NLRP3 inflammasome, and this activation was indepen-
dent of toll-like receptors (TLRs), a major class of innate
immune receptors, which can be involved in the recogni-
tion of both single- and double-stranded RNAs, present in
AluRNA transposons (Sinnett et al. 1991). In general, this
mechanism critically depends on the NF-kB and P2X7
signaling intermediates (Kerur et al. 2013). Therefore, Alu
RNA accumulation in non-immune RPE cells can lead to
the NLRP3 inflammasome activation and RPE cell death,
but the kind of the death is unknown. However, pyroptosis
was excluded, despite activation of caspase-1 by Alu
RNAs. As DICER1 displays anti-apoptotic properties, it
can be speculated that its deficiency can stimulate apopto-
tic mechanisms of cell death (Nekova et al. 2014). This
Fig. 4 Pyroptosis can dominate over apoptosis in retinal pigment epithelium (RPE) cells containing lipofuscin and irradiated with blue light,
when these processes induce activation of the NLRP3 inflammasome
Fig. 5 Normally, Alu RNAs, produced in the transcription of the
Alu transposons, are degraded by the DICER1 endonuclease, but if
its activity decreases, there is an accumulation of the Alu RNAs,
which, in turn, induces the NLRP3 inflammasome resulting in a
caspase-1-independent RPE cell death. The last event can be
modulated by autophagy
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was confirmed by observation that caspase-8 is a critical
mediator of the degeneration of RPE cells associated with
DICER1 deficiency and Alu RNA accumulation (Kim
et al. 2014). The enzyme was activated through the Fas
ligand-dependent pathway, which is typical for the extrin-
sic mode of apoptosis. It was reported that
retrotransposons localized in RNA granules were selec-
tively degraded with the involvement of the NDP52 and
p62 proteins, which are autophagy receptors (Guo et al.
2014). Moreover, mice with inactivated Atg6/Beclin1,
essential for autophagy, accumulated retrotransposon
RNA and insertions in their genomes. Therefore, one can
speculate that impaired autophagy can play a role in AMD
pathogenesis also by supporting Alu RNA accumulation.
The involvement of DICER1 in the degeneration of
RPE cells can be independent of its role in microRNA
(miRNA) biogenesis. However, it was reported that
DICER1 and the EIF2CA/AGO complex, which is es-
sential for miRNA homeostasis, could be degraded by
autophagy, if not loaded with miRNA (reviewed in
Fig. 6 Retinal pigment epithelium (RPE) cells undergoing oxida-
tive stress, which is causative for age-related macular degeneration
(AMD), can die either by necrosis with no involvement of autoph-
agy or by a programmed cell death regulated by autophagy.
Various mechanisms decide about the mode of cell death. When
oxidative stress is generated by blue light, it can induce apoptosis,
but if it is associated with the activation of the NLRP3
inflammasome, pyroptosis can dominate. When oxidative stress
results in DICER1 activity reduction and/or Alu RNA accumula-
tion, it can induce a caspase-1-independent cell death, likely
apoptosis
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Gibbings et al. (2013)). The degradation resulted from
the recognition by the selective autophagy receptor
CALCOCO2/NDP52 (calcium-binding and coiled-coil
domain 2/nuclear dot protein, 52 kDa). Therefore, au-
tophagy can be important in the regulation of the pool of
miRNA-free DICER1, which could target Alu RNA,
and this mechanism can contribute to AMD pathogen-
esis. Several interconnections between autophagy and
miRNA biogenesis were reported in cancer and other
diseases and aging, so it would be useful to relate these
results to AMD (Bao et al. 2016; Tan et al. 2016b;
Zhang et al. 2016).
Conclusions and perspectives
AMD is a major eye disease and emerging health prob-
lem in developed countries with no remedy in general.
Studies on the mechanisms of AMD pathogenesis are
crucial for effective treatment of this disease. As AMD
is a degenerative disease, cell death underlies its pheno-
typic expression. However, the precise mechanism reg-
ulating the death of RPE cells and photoreceptors, cru-
cial for AMD progression, is not known. It should be
taken into account that such mechanism could not be
represented by a simple chain of events, as AMD is a
highly non-homogenous disease with various pheno-
types and severity. The most basic question is whether
AMD-affected cells undergo programmed death or ne-
crosis? Many reports indicate necrosis as the main mode
of RPE cell death in AMD, but some of them describe
rather its programmed version, necroptosis, than fully
uncontrolled cell death (reviewed in Galluzzi et al.
(2011) and Vandenabeele et al. (2010)) (Holler et al.
2000; Murakami et al. 2014). Therefore, programmed
cellular death should be rather linked with AMD
pathogenesis.
Apoptosis is a cell death, which is most often attrib-
uted to AMD. However, similar to necrosis and
necroptosis, some reports indicating apoptotic cell death
in AMD could in fact report pyroptosis instead. As
inflammation can be strongly associated with AMD,
pyroptosis could be a preferential consequence of that
association. Therefore, necroptosis, apoptosis, and
pyroptosis can be considered the main death modes
occurring in RPE cells in AMD (Fig. 6). Executory
pathways of these phenomena are generally indepen-
dent of each other, so the choice of one of them can
determine the fate of the cell. Therefore, the mechanism
of the choice is important for therapeutic strategies in
AMD as it can be targeted to inhibit degeneration of the
retina through the inhibition or delay of death of RPE
cells.
Exploring the role autophagy plays in AMD patho-
genesis, it would be justified to look for the association
between known AMD susceptibility genes and autopha-
gy. Genome-wide association study (GWAS) as well as
earlier studies on AMD genetics revealed many genes,
which variability can be associated with AMD occur-
rence and progression. GWAS and Exome-Chip attitudes
allowed for the identification of more than 50 common
and rare variants at more than 30 loci (Fritsche et al.
Fig. 7 Several experimental
in vitro models to study molecular
aspects of the pathogenesis of
age-related macular degeneration
have been established. ARPE-19
cells are an example of cell
cultures derived from retinal
pigment epithelium (RPE).
Primary RPE cells can be
obtained post-mortem from
humans or laboratory animals
with transgenic modification.
Embryonic pluripotent stem cells
or induced pluripotent stem cells
obtained from individuals with
AMD susceptibility differentiated
into RPE cells can contribute to a
consistent model of AMD
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2016). They can be classified in several ways. One of
them categorizes AMD susceptibility genes into five
main categories: inflammation and immune response, cell
stress response, lipid metabolism and transport, extracel-
lular matrix and cell adhesion, and angiogenesis
(reviewed in Tan et al. (2016a, b)). It should be noted
that the causative role of these genes in AMD pathology
is not fully known. Whether any of these genes can be
closely related to autophagy is an open question. We
showed that ADAMTS9 locus can be considered a can-
didate for such an association (Helisalmi et al. 2014).
However, although there is no solid evidence for link of
autophagy with AMD susceptibility, some autophagy-
related genes can play a role in AMD pathogenesis as
they are important for some general phenomena occur-
ring in the AMD course, and in this review, we tried to
show that autophagy can be involved in AMD-associated
RPE cell death.
At present, there is no appropriate model of AMD.
Human live experiments are excluded, and while there
are many animal models of AMD, no one reflects all
features of human AMD and they have probably more
limitations than strengths (Lyzogubov et al. 2016).
Although stem cell cultures are employed in research
on molecular pathogenesis of AMD, the majority of
in vitro studies on retinal cell death in AMD are per-
formed on RPE-derived cell cultures, mostly the ARPE-
19 cell line (Hsiung et al. 2015) (Fig. 7). There are many
experimental limitations to study cell death in ARPE-19
cells, including heterogeneity of different clones in dif-
ferent laboratories. Moreover, some studies were per-
formed on cell lines with genetic manipulations, addi-
tionally contributing to that heterogeneity. Last, but not
the least, AMD is a systemic disease and not just an RPE
disorder. Nevertheless, detailed studies on mechanism
of cellular death in AMDmay be performed only on cell
in culture. However, there are at least two other major
problems associated with the use of cell lines. Firstly,
AMD is an age-related disease and RPE cells in the
macula are post-mitotic, so their aging in situ may differ
from this process occurring in a culture. Moreover,
ARPE-19 populations can contain a substantial, if not
major, fraction of cells which are able to double their
population to over 270 times, so they can be considered
immortal, and mechanisms of cell death in mortal and
immortal cells can be different (Kozlowski 2015).
Furthermore, senescence may not be the only reason
for the difference between RPE cells in vivo and
in vitro and internal heterogeneity within ARPE-19
population (reviewed in Kozlowski (2012)). Secondly,
the exact mechanism of triggering cellular death in
AMD, leading tomacular degeneration, is not complete-
ly known; thus, a study of death in cell culture is
somehow arbitrary as it can depend on the factor to
induce that effect.
Therapeutic strategy targeting the mechanism regu-
lating RPE cell death would be useful as it could be a
universal strategy for AMD. At present, the only effec-
tive treatment for AMD is based on the use of anti-
VEGF in the wet form of the disease. There is no
remedy for GA in the dry AMD. However, as we tried
to stress in our review, the mechanism of determination
of RPE cell death is far from completeness. We tried to
show that autophagy was involved in most cases of
AMD-related death of RPE cells. This involvement is
underlined by the role inflammation plays in AMD
pathogenesis and regulat ion of the NLRP3
inflammasome, playing a central role in both dry and
wet forms of the disease, by autophagy. Therefore,
research on the inhibition of NLRP3 activation by au-
tophagy proteins should search for detailed mechanisms
of this interaction, projecting some chemical or/and
genetic modulators of this interaction.
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